Upstate Active Clinical Trials
Study Title:
A Study to Assess the Utility of MDM2/CDK4 Immunohistochemistry of a Tru-Cut Biopsy toDifferentiate Between Benign Lipomas and Atypical Lipomatous Tumor/Well-Differentiated Liposarcoma
(“ALT/WDLS”)
What is the purpose of the study? (in Layman's terms, please describe the study)
This research study is being conducted to determine if performing a pre-operative core biopsy of the tumor and testing the biopsy material using immunohistochemical analyses can distinguish an atypical lipomatous tumor (ALT/WDLS) from a benign lipoma.Upstate Institutional Review Board (IRB) Number:
1203583Study Phase:
N/APatient Age Group:
AdultsPrincipal Investigator:
Timothy A DamronWho can I contact for more information?
Name: Tina M Craig
Phone: 315-464-8618
Email: [email protected]